| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
865,224 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
484,602 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,100,996 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
70 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Siegall Clay B |
President and CEO |
• • – |
2014-08-11 |
4 |
OE |
$5.92 |
$15,984 |
D/D |
2,700 |
527,917 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-13 |
4 |
B |
$39.80 |
$3,533,527 |
I/I |
88,587 |
416,208 |
2.25 |
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-12 |
4 |
B |
$39.84 |
$5,112,199 |
I/I |
128,008 |
414,067 |
2.25 |
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2014-06-10 |
4 |
AS |
$40.14 |
$449,574 |
D/D |
(11,200) |
525,217 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2014-06-10 |
4 |
OE |
$5.92 |
$66,304 |
D/D |
11,200 |
536,417 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-09 |
4 |
B |
$38.56 |
$9,772,651 |
I/I |
251,093 |
410,974 |
2.25 |
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-06 |
4 |
B |
$37.40 |
$6,546,471 |
I/I |
174,987 |
404,906 |
2.25 |
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-05 |
4 |
B |
$37.63 |
$4,526,317 |
I/I |
120,172 |
400,672 |
2.25 |
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-04 |
4 |
B |
$36.04 |
$3,145,161 |
I/I |
87,042 |
397,765 |
2.25 |
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-03 |
4 |
B |
$34.38 |
$3,457,722 |
I/I |
100,304 |
395,659 |
2.25 |
- |
|
| 14159, L.p. |
Director |
– • • |
2014-06-02 |
4 |
B |
$34.05 |
$3,225,210 |
I/I |
94,617 |
393,233 |
2.25 |
- |
|
| Welch Daniel G |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
13,119 |
|
- |
|
| Lippman Marc E |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
124,950 |
|
- |
|
| Simonian Nancy A |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
7,000 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
17,405 |
|
- |
|
| Mclaughlin John Peter |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
32,000 |
|
- |
|
| Gryska David W |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
25,250 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2014-05-16 |
4 |
B |
$34.03 |
$5,734,196 |
I/I |
168,411 |
390,944 |
2.25 |
- |
|
| 14159, L.p. |
Director |
– • • |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
I/I |
10,500 |
386,872 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2014-05-15 |
4 |
B |
$34.10 |
$726,356 |
I/I |
21,200 |
383,372 |
2.25 |
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2014-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
325,479 |
525,217 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2014-05-14 |
4 |
OE |
$7.26 |
$217,800 |
I/I |
30,000 |
382,860 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2014-05-09 |
4/A |
B |
$33.73 |
$4,715,922 |
I/I |
138,073 |
372,860 |
2.25 |
- |
|
| Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
• – – |
2014-05-09 |
4 |
S |
$35.00 |
$350,000 |
D/D |
(10,000) |
55,519 |
|
- |
|
| Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
• – – |
2014-05-09 |
4 |
OE |
$9.23 |
$92,300 |
D/D |
10,000 |
65,519 |
|
- |
|
1805 Records found
|
|
Page 38 of 73 |
|
|
